
Sofimac Investment Managers
Description
Sofimac Partners, headquartered in Clermont-Ferrand, France, is a prominent venture capital firm with a long-standing commitment to supporting small and medium-sized enterprises (SMEs) across France. While the user's query referred to "Sofimac Investment Managers," the entity is widely known as Sofimac Partners, managing a diverse portfolio of funds tailored to different stages of company development. The firm's core mission revolves around providing financial support for the medium- and long-term growth of innovative and promising businesses, primarily within the French regions.
The firm employs a multi-fund strategy, enabling it to invest across various stages, from seed and early-stage venture capital to growth equity and even transmission capital for management buyouts. Their investment philosophy emphasizes proximity to entrepreneurs, offering not just capital but also strategic guidance and network access. Sofimac Partners has a strong regional focus, particularly active in the Auvergne-Rhône-Alpes region, but also extending its reach to other dynamic economic basins throughout France. This localized approach allows them to deeply understand the specific needs and opportunities within their target markets.
Sofimac Partners has established itself as a significant player in the French private equity landscape. The firm currently manages over $540 million (equivalent to over €500 million) in assets under management, demonstrating its substantial financial capacity and commitment to the ecosystem. Since its inception, Sofimac Partners has invested in more than 400 companies, showcasing a broad and active investment history. Their typical first cheques for venture and growth capital range from approximately $108,000 for early-stage ventures up to $5,400,000 for more mature growth opportunities, reflecting their versatile investment capabilities designed to meet the evolving needs of SMEs.
Investor Profile
Sofimac Investment Managers has backed more than 73 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 11% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in France, Italy, Bermuda.
- Strong thematic focus on Biotechnology, Health Care, Manufacturing.
- Typical check size: $108K – $5.4M.
Stage Focus
- Series Unknown (49%)
- Seed (19%)
- Series A (12%)
- Series B (8%)
- Private Equity (4%)
- Undisclosed (1%)
- Post Ipo Equity (1%)
- Convertible Note (1%)
- Series C (1%)
- Grant (1%)
Country Focus
- France (93%)
- Italy (3%)
- Bermuda (1%)
- Austria (1%)
- United States (1%)
Industry Focus
- Biotechnology
- Health Care
- Manufacturing
- Medical Device
- Software
- Medical
- Construction
- Electronics
- Information Technology
- Chemical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.